Inactive Instrument
F-star Therapeutics, Inc. Stock
Stocks
FSTX
US30315R1077
Biotechnology & Medical Research
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/3/23 | Tender | Director | 43,937 | 0.1999% | ||
| 8/3/23 | Tender | Chief Technology Officer | 183,777 | 0.8360% | ||
| 8/3/23 | Issuer sale | Director | 48,322 | 0.2198% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +27.14% | - | - | 157M | |
| +1.10% | -2.67% | +62.79% | +70.47% | 68.45B | |
| +0.77% | +9.54% | +16.23% | +94.22% | 61.31B | |
| +0.08% | +0.48% | +20.63% | +98.63% | 55.73B | |
| -0.96% | +7.41% | +10.20% | +108.91% | 47.51B | |
| -1.25% | +2.35% | +22.74% | +38.34% | 44.68B | |
| -2.41% | -0.73% | +167.89% | +794.72% | 38.14B | |
| +1.21% | -2.56% | +20.27% | +52.81% | 35.85B | |
| -1.01% | -1.05% | +77.65% | +54.56% | 33.05B | |
| -2.22% | +8.56% | -39.26% | +397.14% | 25.9B | |
| Average | -0.47% | +2.67% | +39.90% | +189.98% | 46B | |
| Weighted average by Cap. | -0.28% | +2.84% | +40.48% | +163.85% |
Employees
35
